Current Drug Therapy Recommendations for the Treatment of Endometriosis
Tóm tắt
The principal symptoms and signs of endometriosis are tissue lesions and pelvic pain. These occur to varying degrees, with a chronic pattern and a tendency for deterioration with time. Patients with endometriosis often also have fertility problems, but the relationship between this and the signs and symptoms of the disease is inconsequent; the basic pathophysiology is not exactly known. Although an immunological defect resulting in an inflammatory reaction around discharged menstrual debris in the pelvic cavity has been shown, no treatments based on this process are available. Estrogen often plays an important role in the progression of lesions and pain. Therefore, the aim of treatment usually has been to downregulate the ovaries and/or give antiestrogenic drugs as an alternative to surgical removal. As complete downregulation of the ovaries and hypoestrogenaemia does not seem to be crucial, achievement of amenorrhoea seems to be sufficient. This means that women may continue to have circulating estrogen levels so that severe hypoestrogenic adverse effects such as bone déminéralisation, dry vagina, psychiatric symptoms or anabolic/androgenic effects of gestagens can be avoided. However, as both symptoms and the dependence of hormones may vary between and within women, the treatment needs to be individualised. There are a number of available treatments for endometriosis on the market and it is important for the doctor to know how to reach the therapeutic window of these treatments for each woman. It is also important to inform the patient about the different possibilities so that the treatment with the least impact on her quality of life can be chosen. When the therapeutic window has been identified, the treatment may then either be continued for a long period of time or be repeated when needed.
Tài liệu tham khảo
citation_journal_title=Am J Obstet Gynecol; citation_title=Is pelvic endometriosis always associated with chronic pain? A retrospective study of 618 cases diagnosed by laparoscopy; citation_author=T Fukaya, H Hoshiai, A Yajima; citation_volume=169; citation_publication_date=1993; citation_pages=719-22; citation_id=CR1
citation_journal_title=J Reprod Med; citation_title=Prevalence of endometriosis in asymptomatic women; citation_author=JMR Rawson; citation_volume=36; citation_publication_date=1991; citation_pages=513-5; citation_id=CR2
citation_journal_title=Hum Reprod; citation_title=Is mild endometriosis always a disease?; citation_author=P Vercellini, L Bocciolone, PG Crosignani; citation_volume=7; citation_publication_date=1992; citation_pages=627-9; citation_id=CR3
citation_journal_title=Baillieres Clin Obstet Gynaecol; citation_title=Is endometriosis a disease?; citation_author=PG Wardle, MG Hull; citation_volume=7; citation_publication_date=1993; citation_pages=673-85; citation_doi=10.1016/S0950-3552(05)80457-2; citation_id=CR4
citation_journal_title=Human Reprod; citation_title=Is mild endometriosis a condition occuring intermittently in all women?; citation_author=PR Koninckx; citation_volume=9; citation_publication_date=1994; citation_pages=2202-5; citation_id=CR5
citation_journal_title=Ann N Y Acad Sci; citation_title=Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease; citation_author=PR Koninckx, D Oosterlynck, T D’Hooghe; citation_volume=734; citation_publication_date=1994; citation_pages=333-41; citation_doi=10.1111/j.1749-6632.1994.tb21763.x; citation_id=CR6
citation_journal_title=Hum Reprod; citation_title=Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study; citation_author=J Balasch, M Creus, F Fabregues; citation_volume=11; citation_publication_date=1996; citation_pages=387-91; citation_doi=10.1093/HUMREP/11.2.387; citation_id=CR7
citation_journal_title=Obstet Gynecol Clin North Am; citation_title=Immunology and endometriosis; citation_author=JA Hill; citation_volume=24; citation_publication_date=1997; citation_pages=291-306; citation_doi=10.1016/S0889-8545(05)70305-3; citation_id=CR8
citation_journal_title=Fertil Steril; citation_title=Age-related evolution in colour appearance of endometriosis; citation_author=DB Redwine; citation_volume=48; citation_publication_date=1987; citation_pages=1062-3; citation_id=CR9
citation_journal_title=Fertil Steril; citation_title=Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence; citation_author=A Bergqvist, M Fernö; citation_volume=60; citation_publication_date=1993; citation_pages=63-8; citation_id=CR10
citation_journal_title=Human Reprod; citation_title=Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: a review; citation_author=A Bergqvist; citation_volume=10; citation_publication_date=1995; citation_pages=446-52; citation_doi=10.1093/humrep/10.1.11; citation_id=CR11
citation_journal_title=Fertil Steril; citation_title=Dysmenorrhea is related to the number of implants in endometriosis patients; citation_author=MM Perper, F Nezhat, H Goldstein; citation_volume=63; citation_publication_date=1995; citation_pages=500-3; citation_id=CR12
citation_journal_title=Fertil Steril; citation_title=Endometriosis and pelvic pain: relation to disease stage and localization; citation_author=P Vercellini, L Trespidi, O Giorgi; citation_volume=65; citation_publication_date=1996; citation_pages=299-304; citation_id=CR13
citation_journal_title=Fertil Steril; citation_title=Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain; citation_author=DW Stovall, LM Bowser, DF Archer; citation_volume=68; citation_publication_date=1997; citation_pages=13-8; citation_doi=10.1016/S0015-0282(97)81468-9; citation_id=CR14
citation_journal_title=Semin Reprod Endocrinol; citation_title=Endometriosis: what a pain it is; citation_author=P Vercellini; citation_volume=15; citation_publication_date=1997; citation_pages=251-61; citation_doi=10.1055/s-2008-1068755; citation_id=CR15
citation_journal_title=Obstet Gynecol; citation_title=Endometriosis persisting after castration: clinical characteristics and results of surgical management; citation_author=DB Redwine; citation_volume=83; citation_publication_date=1994; citation_pages=405-13; citation_id=CR16
citation_journal_title=Fertil Steril; citation_title=Incidence of symptom recurrence after hysterectomy for endometriosis; citation_author=AB Namnoum, TN Hickman, SB Goodman; citation_volume=64; citation_publication_date=1995; citation_pages=898-902; citation_id=CR17
citation_journal_title=Fertil Steril; citation_title=Gonadotrophin-releasing hormone analogues for the treatment of endometriosis: long term follow-up; citation_author=KG Waller, RW Shaw; citation_volume=59; citation_publication_date=1993; citation_pages=511-4; citation_id=CR18
citation_journal_title=Fertil Steril; citation_title=Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis; citation_author=MD Hornstein, R Hemmings, AA Yuzpe; citation_volume=68; citation_publication_date=1997; citation_pages=860-4; citation_doi=10.1016/S0015-0282(97)00360-9; citation_id=CR19
citation_title=Evaluation of treatment with gonadotrophin-releasing hormone analogues; citation_inbook_title=Endometriosis: current understanding and management; citation_publication_date=1995; citation_pages=206-34; citation_id=CR20; citation_author=RW Shaw; citation_publisher=Blackwell Science
citation_journal_title=Int J Fertil Menopaus Stud; citation_title=Pain of endometriosis: effects of nafarelin and danazol therapy; citation_author=GD Adamson, L Kwei, RA Edgren; citation_volume=39; citation_publication_date=1994; citation_pages=215-7; citation_id=CR21
citation_journal_title=Fertil Steril; citation_title=Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group; citation_author=AM Dlugi, JD Miller, J Knittle; citation_volume=54; citation_publication_date=1990; citation_pages=419-27; citation_id=CR22
citation_journal_title=Clin Endocrinol; citation_title=A randomized double-blind placebo-controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone; citation_author=JM Eldred, PJ Haynes, EJ Thomas; citation_volume=37; citation_publication_date=1992; citation_pages=354-9; citation_doi=10.1111/j.1365-2265.1992.tb02338.x; citation_id=CR23
citation_journal_title=Fertil Steril; citation_title=Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis; citation_author=P Kiilholma, R Tuimala, S Kivinen; citation_volume=64; citation_publication_date=1995; citation_pages=903-8; citation_id=CR24
citation_journal_title=Am J Obstet Gynecol; citation_title=A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment; citation_author=T Mukherjee, D Barad, R Turk; citation_volume=175; citation_publication_date=1996; citation_pages=105-9; citation_doi=10.1016/S0002-9378(96)70258-2; citation_id=CR25
citation_journal_title=Obstet Gynecol; citation_title=Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group; citation_author=MD Hornstein, ES Surrey, GW Weisberg; citation_volume=91; citation_publication_date=1998; citation_pages=16-24; citation_doi=10.1016/S0029-7844(97)00620-0; citation_id=CR26
citation_journal_title=Fertil Steril; citation_title=The effects of trip-torelin versus placebo on the symptoms of endometriosis; citation_author=A Bergqvist, T Bergh, L Hogström; citation_volume=69; citation_publication_date=1998; citation_pages=702-8; citation_doi=10.1016/S0015-0282(98)00019-3; citation_id=CR27
citation_journal_title=Gynecol Endocrinol; citation_title=Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery system and dose; citation_author=HA Leusden; citation_volume=8; citation_publication_date=1994; citation_pages=215-22; citation_doi=10.3109/09513599409072458; citation_id=CR28
citation_journal_title=Acta Obstet Gynecol Scand; citation_title=Hormonal therapies for endometriosis: implications for bone metabolism; citation_author=MY Dawood; citation_volume=159; citation_publication_date=1994; citation_pages=22-34; citation_id=CR29
citation_journal_title=Fertil Steril; citation_title=Bone density and endometriosis; citation_author=T Dochi, B Lees, M Sidhu; citation_volume=61; citation_publication_date=1994; citation_pages=175-7; citation_id=CR30
citation_journal_title=J Clin Endocrinol Metab; citation_title=Biochemical markers of bone turnover in lactating and nonlactating postpartum women; citation_author=M Sowers, D Eyre, BW Hollis; citation_volume=80; citation_publication_date=1995; citation_pages=2210-6; citation_doi=10.1210/jc.80.7.2210; citation_id=CR31
citation_journal_title=Osteroporos Int; citation_title=Bone turnover and density in healthy women during breastfeeding and after weaning; citation_author=JM Lopez, G Gonzalez, V Reyes; citation_volume=6; citation_publication_date=1996; citation_pages=153-9; citation_doi=10.1007/BF01623940; citation_id=CR32
citation_journal_title=Maturitas; citation_title=The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism; citation_author=K Hashimoto, M Nozaki, Y Inoue; citation_volume=22; citation_publication_date=1995; citation_pages=185-91; citation_doi=10.1016/0378-5122(95)00940-M; citation_id=CR33
citation_journal_title=Int J Gynaecol Obstet; citation_title=Bone loss rate in lumbar spine: a comparison between natural and surgically induced menopause; citation_author=A Yildiz, I Sahin, K Gol; citation_volume=55; citation_publication_date=1996; citation_pages=153-9; citation_doi=10.1016/S0020-7292(96)02756-7; citation_id=CR34
citation_journal_title=Maturitas; citation_title=Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered; citation_author=R Revilla, M Revilla, ER Hernandez; citation_volume=22; citation_publication_date=1995; citation_pages=145-50; citation_doi=10.1016/0378-5122(95)00929-F; citation_id=CR35
citation_journal_title=Hum Reprod Update; citation_title=Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal add-back paradigms; citation_author=EY Adashi; citation_volume=9; citation_publication_date=1994; citation_pages=1380-97; citation_id=CR36
citation_journal_title=Obstet Gynecol; citation_title=Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist; citation_author=KA Steingold, M Cedars, JK Lu; citation_volume=69; citation_publication_date=1987; citation_pages=403-11; citation_id=CR37
citation_journal_title=Clin Endocrinol; citation_title=Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH-agonist implant or by danazol; citation_author=A Lemay, NA Brideau, JC Forest; citation_volume=35; citation_publication_date=1991; citation_pages=305-10; citation_doi=10.1111/j.1365-2265.1991.tb03541.x; citation_id=CR38
citation_journal_title=Menopause: JNorth Am Menopause Soc; citation_title=Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin: effect on bone turnover and bone mass; citation_author=P Ravn, A Bergqvist, MA Hansen; citation_volume=1; citation_publication_date=1994; citation_pages=11-7; citation_id=CR39
citation_journal_title=Fertil Steril; citation_title=Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone ‘add-back’ therapy; citation_author=ES Surrey, B Voigt, N Fournet; citation_volume=63; citation_publication_date=1995; citation_pages=747-55; citation_id=CR40
citation_journal_title=Clin Endocrinol; citation_title=Suppression of ovarian activity by Zoladex depot (ICI 118630): a long-acting luteinizing hormone releasing hormone agonist analogue; citation_author=CP West, DT Baird; citation_volume=26; citation_publication_date=1987; citation_pages=213-20; citation_doi=10.1111/j.1365-2265.1987.tb00779.x; citation_id=CR41
citation_journal_title=Am J Obstet Gynecol; citation_title=Hormone treatment of endometriosis: the estrogen threshold hypothesis; citation_author=RL Barbieri; citation_volume=166; citation_publication_date=1992; citation_pages=740-5; citation_id=CR42
citation_journal_title=Gynecol Obstet Invest; citation_title=Nafarelin in the treatment of endometriosis; citation_author=ME Hull, RL Barbieri; citation_volume=37; citation_publication_date=1994; citation_pages=263-4; citation_doi=10.1159/000292574; citation_id=CR43
citation_journal_title=Gynecol Endocrinol; citation_title=A double-blind randomized study of the treatment of endometriosis with nafarelin versus nafarelin plus norethisterone; citation_author=A Bergqvist, J Jacobson, S Harris; citation_volume=11; citation_publication_date=1997; citation_pages=187-94; citation_doi=10.3109/09513599709152533; citation_id=CR44
citation_journal_title=Br J Obstet Gynecol; citation_title=Add-back therapy in the treatment of endometriosis: the European experience; citation_author=DK Edmonds; citation_volume=103; citation_publication_date=1996; citation_pages=10-3; citation_id=CR45
citation_journal_title=Fertil Steril; citation_title=Gonadotropin-releasing hormone agonist plus estrogen-progestin ‘add-back’ therapy for endo-metriosis-related pelvic pain; citation_author=AJ Friedman, MD Hornstein; citation_volume=60; citation_publication_date=1993; citation_pages=236-41; citation_id=CR46
citation_journal_title=Human Reprod; citation_title=Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability; citation_author=LE Caird, CP West, MA Lumsden; citation_volume=12; citation_publication_date=1997; citation_pages=436-40; citation_doi=10.1093/humrep/12.3.436; citation_id=CR47
citation_journal_title=Fertil Steril; citation_title=Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial; citation_author=R Howell, DK Edmonds, M Dowsett; citation_volume=64; citation_publication_date=1995; citation_pages=474-81; citation_id=CR48
citation_journal_title=Fertil Steril; citation_title=A randomized, double-blind, placebo-controlled study of luteal phase dydro-gesterone (Duphaston) in women with minimal to mild endometriosis; citation_author=CE Overton, PC Lindsay, B Johal; citation_volume=62; citation_publication_date=1994; citation_pages=701-7; citation_id=CR49
citation_journal_title=Fertil Steril; citation_title=Progestins for symptomatic endometriosis: a critical analysis of the evidence; citation_author=P Vercellini, I Cortesi, PG Crosignani; citation_volume=68; citation_publication_date=1997; citation_pages=393-401; citation_doi=10.1016/S0015-0282(97)00193-3; citation_id=CR50
citation_journal_title=New Trends Gynecol Obstet; citation_title=A Clinical pharma-cokinetic and pharmacodynamic study of three progestogens in the treatment of endometriosis; citation_author=A Bergqvist, B-M Landgren, E Diczfalusy; citation_volume=4; citation_publication_date=1988; citation_pages=65-84; citation_id=CR51
citation_journal_title=Maturitas; citation_title=Lipid metabolic changes during hormonal treatment of endometriosis; citation_author=AT Teichmann, P Cremer, H Wieland; citation_volume=10; citation_publication_date=1988; citation_pages=27-33; citation_doi=10.1016/0378-5122(88)90128-4; citation_id=CR52
citation_journal_title=Eur J Obstet Gynecol Reprod Biol; citation_title=Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate; citation_author=S Telimaa, D Apter, M Reinila; citation_volume=36; citation_publication_date=1990; citation_pages=97-105; citation_doi=10.1016/0028-2243(90)90055-6; citation_id=CR53
citation_journal_title=Am J Obstet Gynecol; citation_title=Depot medroxyprogesterone acetete versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis; citation_author=P Vercillini, O Giorgi, S Oldani; citation_volume=175; citation_publication_date=1996; citation_pages=396-401; citation_doi=10.1016/S0002-9378(96)70152-7; citation_id=CR54
citation_journal_title=Contraception; citation_title=Hormonal effects of the 300μg norethisterone (NET) minipill. 1. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration; citation_author=B-M Landgren, E Diczfalusy; citation_volume=21; citation_publication_date=1980; citation_pages=87-113; citation_doi=10.1016/0010-7824(80)90142-0; citation_id=CR55
citation_journal_title=Fertil Steril; citation_title=Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis; citation_author=S Telimaa, I Penttila, J Poulakka; citation_volume=52; citation_publication_date=1989; citation_pages=31-5; citation_id=CR56
citation_journal_title=Cardiologia; citation_title=Ovarian hormones and the cardiovascular system: recent findings; citation_author=GM Rosano, PM Sarrel; citation_volume=39; citation_publication_date=1994; citation_pages=275-9; citation_id=CR57
citation_journal_title=Fertil Steril; citation_title=Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study; citation_author=; citation_volume=66; citation_publication_date=1996; citation_pages=911-9; citation_id=CR58
citation_journal_title=Fertil Steril; citation_title=Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up; citation_author=RL Barbieri, S Evans, RW Kistner; citation_volume=37; citation_publication_date=1982; citation_pages=737-46; citation_id=CR59
citation_journal_title=Hum Reprod Suppl; citation_title=Medical treatment of symptomatic endometriosis; citation_author=U Cirkel; citation_volume=11; citation_publication_date=1996; citation_pages=89-101; citation_doi=10.1093/humrep/11.suppl_3.89; citation_id=CR60
citation_journal_title=Fertil Steril; citation_title=Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study; citation_author=P Vercillini, L Trespidi, S Panazza; citation_volume=62; citation_publication_date=1994; citation_pages=1136-42; citation_id=CR61
citation_journal_title=Acta Obstet Gynecol Scand; citation_title=Regression of endo-metriosis following shorter treatment with, or lower dose of danazol: comparison of pre-and post-treatment laparoscopic findings in the Scandinavian multicentre study; citation_author=A Döberl, A Bergqvist, S Jeppsson; citation_volume=123; citation_publication_date=1984; citation_pages=51-8; citation_doi=10.3109/00016348409156982; citation_id=CR62
citation_journal_title=Fertil Steril; citation_title=Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain; citation_author=MD Hornstein, AA Yuzpe, KA Burry; citation_volume=63; citation_publication_date=1995; citation_pages=955-62; citation_id=CR63
citation_journal_title=Fertil Steril; citation_title=Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients; citation_author=JR Zorn, J Mathieson, F Risquez; citation_volume=53; citation_publication_date=1990; citation_pages=401-6; citation_id=CR64
citation_journal_title=Am J Obstet Gynecol; citation_title=Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel); citation_author=GD Adamson, WL Heinrichs, MR Henzl; citation_volume=177; citation_publication_date=1997; citation_pages=1413-8; citation_doi=10.1016/S0002-9378(97)70084-X; citation_id=CR65
citation_journal_title=Fertil Steril; citation_title=Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety and bone mineral density; citation_author=MD Hornstein, AA Yuzpe, KA Burry; citation_volume=67; citation_publication_date=1997; citation_pages=1013-8; citation_doi=10.1016/S0015-0282(97)81432-X; citation_id=CR66
citation_journal_title=Drugs; citation_title=Dysmenorrhoea and prostaglandin’s: pharmacological and therapeutic considerations; citation_author=MY Dawood; citation_volume=22; citation_publication_date=1981; citation_pages=42-56; citation_doi=10.2165/00003495-198122010-00003; citation_id=CR67
citation_journal_title=J Am Assoc Gynecol Laparosc; citation_title=Evaluation and management of chronic pelvic pain; citation_author=AT Duleba, MD Keltz, DL Olive; citation_volume=3; citation_publication_date=1996; citation_pages=205-27; citation_doi=10.1016/S1074-3804(96)80004-1; citation_id=CR68
citation_journal_title=Am J Obstet Gynecol; citation_title=Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea; citation_author=PR Owen; citation_volume=148; citation_publication_date=1984; citation_pages=96-103; citation_id=CR69
citation_journal_title=Gynecol Endocrinol; citation_title=Different types of extregenital endometriosis: a review; citation_author=A Bergqvist; citation_volume=7; citation_publication_date=1993; citation_pages=1-15; citation_doi=10.3109/09513599309152504; citation_id=CR70